Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
BASEL, SWITZERLAND/CALIFORNIA, US: Lonza and Eclipse Therapeutics announced an agreement for the production of Eclipse’s novel cancer therapeutic antibody, ET-101, using Light Path Development Services. ET-101 is under investigation for the inhibition of the growth of cancer stem cells. Under the agreement, Lonza will produce phase 1 clinical material at its development and manufacturing facility in Slough, UK. Eliminating cancer stem cells represents a new cancer treatment paradigm that could offer a distinct advantage over existing strategies and a solution for chemoresistance.
“Lonza’s best-in-class antibody manufacturing capabilities will greatly support our development strategy to deliver the highest quality and most effective therapeutics targeting cancer stem cells. Moving into cell line development and subsequent manufacturing represents an important milestone for Eclipse,” said Dr Christopher Reyes, Chief Security Officer, Eclipse Therapeutics.
© WOC News
Login
SEOUL, SOUTH KOREA: South Korea’s parliament has delayed vote on an emission trading scheme scheduled, because of political wrangling between ...
TOKYO, JAPAN/ RIYADH, SAUDI ARABIA: The Saudi Basic Industries Corporation (SABIC) has signed a toluene diisocyanate (TDI) and methylene di-para-pheny ...
SWINDON, UK: EPSRC invites expressions of interests to bid into the call for proposals in graphene engineering research. The aim of the call is to foc ...
DES MOINES, US/ADELAIDE, AUSTRALIA: DuPont and the Australian Centre for Plant Functional Genomics (ACPFG) announced that they have expanded their lon ...
VISAKHAPATNAM, INDIA: Recently, SNF India formally inaugurated its new chemical plant set up in the Jawaharlal Nehru Pharma city in Visakhapatnam dist ...
SHIJIAZHUANG, CHINA: The death toll in chemical plant explosion has climbed to 16, and 43 others were hospitalized with injuries, authorities in north ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder